Kathmandu, March 26, 2026 – Today is the last day for applying for the IPO of Sopan Pharmaceuticals Limited, which has been floated for Nepalis working abroad.
The IPO of Sopan Pharmaceuticals was floated on March 23 and is only available for foreign employed investors at this time. Investors can apply for this IPO through C-ASBA-approved banks and financial institutions or through Meroshare. The IPO will end today.
The company is floating 25 percent of its issued capital worth Rs 1.71 billion. Accordingly, a total of 4,290,000 units of shares worth Rs 429 million will be floated for public investors. Out of this total number of shares, 429,000 units worth Rs 42.9 million will be for foreign-employed Nepalis.
In addition, 214,500 units will be reserved for mutual funds and 171,600 units for company employees. The rest, 3,474,900 units, will be available at a later date for the general public to invest in.
The minimum number of shares that can be applied for is 10, and the maximum is 11,000. The IPO manager for this IPO is NMB Capital Limited.
As per CARE Ratings Nepal, the company has been given a rating of ‘CARE-NP B,’ which is a high-risk investment. However, investors should be aware of this before investing in this IPO.
As the deadline is ending today, interested investors should apply for this IPO at the earliest to avoid missing this golden opportunity.
Stay tuned to NepseTalk for the latest news.
लोड हुँदैछ...
0 Comments